Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Rofecoxib

1

VIII.a Angioedema (may cause UAO, asphyxia and death)

1
Last update : 13/09/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
COX2 inhibitors
2

Publications

Angioedema associated with aspirin and rofecoxib.
The Annals of pharmacotherapy 2005 May;39;944-8 2005 May
Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study.
British journal of clinical pharmacology 2003 Feb;55;166-74 2003 Feb
Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib.
Postgraduate medical journal 2002 Jul;78;439-40 2002 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies